Sansure Biotech(SH:688289) Ge Long Hui A P P·2025-10-09 08:59Core Viewpoint - The article discusses the investment of the actual controller of Shengxiang Biology, Dai Lizhong, in a controlled nuclear fusion company, Shanghai Honghu Fusion, which is the first commercial fusion enterprise in China focusing on high-temperature superconducting stellarator technology [1] Company Summary - Shengxiang Biology confirmed that Shanghai Honghu Fusion was founded in 2023 and is backed by Dai Lizhong, who is also the chairman of Shengxiang Biology [1] - Dai Lizhong does not participate in the daily operations of Honghu Fusion, aiming to provide a platform for world-class scientists and engineers in the field [1] - The investment in Honghu Fusion is currently a personal investment by Dai Lizhong, and any potential investment by the listed company will be decided based on actual development needs and strategic planning [1]